Literature DB >> 24969737

The effect of topical corticosteroids, topical antihistamines, and preservatives on human ciliary beat frequency.

Jian Jiao1, Na Meng, Luo Zhang.   

Abstract

BACKGROUND: The aim of this study was to investigate the effect of the corticosteroids, the antihistamines, and the preservatives benzalkonium chloride (BKC) and potassium sorbate (PS) in intranasal medications on human nasal epithelial ciliary beat frequency (CBF).
METHODS: Primary ciliated epithelial cell cultures from the human nasal mucosa of chronic sinusitis patients were established. Changes in CBF of epithelial cell cultures treated/untreated with intranasal medications or preservatives were assessed using high-speed digital imaging methods.
RESULTS: Budesonide caused a rapid but reversible ciliostasis and showed no ciliotoxic effect at 10% dilution. Fluticasone propionate induced an irreversible ciliostatic activity and showed a reversible decrease in CBF at 10% dilution. Azelastine hydrochloride and levocabastine hydrochloride both induced a dose-dependent and irreversible decrease in CBF, although the ciliotoxic effect was not evident at 5% dilution. BKC resulted in an irreversible ciliostasis at 0.005 or 0.01% concentrations, whereas PS did not show any change in CBF at 0.12 or 0.24% concentrations.
CONCLUSIONS: Crystalline BKC and BKC-containing intranasal medications, including fluticasone propionate, azelastine hydrochloride and levocabastine hydrochloride, but not PS or PS-containing intranasal budesonide spray, led to irreversible ciliostasis in human nasal epithelial cell cultures when applied at clinically relevant concentrations.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24969737     DOI: 10.1159/000363575

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  7 in total

1.  Pharmacogenomics and Placebo Response in a Randomized Clinical Trial in Asthma.

Authors:  Rui-Sheng Wang; Damien C Croteau-Chonka; Edwin K Silverman; J Loscalzo; Scott T Weiss; Kathryn T Hall
Journal:  Clin Pharmacol Ther       Date:  2019-10-28       Impact factor: 6.875

2.  Influence of MP 29-02 on ciliary beat frequency in human epithelial cells in vitro.

Authors:  D Häussler; J U Sommer; A Nastev; C Aderhold; A Wenzel; B Kramer; B A Stuck; R Birk
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-19       Impact factor: 2.503

3.  Cilia Stimulatory and Antibacterial Activities of T2R Bitter Taste Receptor Agonist Diphenhydramine: Insights into Repurposing Bitter Drugs for Nasal Infections.

Authors:  Li Eon Kuek; Derek B McMahon; Ray Z Ma; Zoey A Miller; Jennifer F Jolivert; Nithin D Adappa; James N Palmer; Robert J Lee
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-06

4.  Identification of drugs that restore primary cilium expression in cancer cells.

Authors:  Niamat Ali Khan; Nicolas Willemarck; Ali Talebi; Arnaud Marchand; Maria Mercedes Binda; Jonas Dehairs; Natalia Rueda-Rincon; Veerle W Daniels; Muralidhararao Bagadi; Deepak Balaji Thimiri Govinda Raj; Frank Vanderhoydonc; Sebastian Munck; Patrick Chaltin; Johannes V Swinnen
Journal:  Oncotarget       Date:  2016-03-01

5.  Assessment of respiratory and systemic toxicity of Benzalkonium chloride following a 14-day inhalation study in rats.

Authors:  Hye-Yeon Choi; Yong-Hoon Lee; Cheol-Hong Lim; Yong-Soon Kim; In-Seop Lee; Ji-Min Jo; Ha-Young Lee; Hyo-Geun Cha; Hee Jong Woo; Dong-Seok Seo
Journal:  Part Fibre Toxicol       Date:  2020-01-28       Impact factor: 9.400

6.  Fast effectiveness of a solubilized low-dose budesonide nasal spray in allergic rhinitis.

Authors:  Petra Zieglmayer; René Schmutz; Patrick Lemell; Nicole Unger-Manhart; Sabine Nakowitsch; Andreas Goessl; Markus Savli; René Zieglmayer; Eva Prieschl-Grassauer
Journal:  Clin Exp Allergy       Date:  2020-07-07       Impact factor: 5.018

7.  Rhinosectan® spray (containing xyloglucan) on the ciliary function of the nasal respiratory epithelium; results of an in vitro study.

Authors:  Núria Piqué; Barbara De Servi
Journal:  Allergy Asthma Clin Immunol       Date:  2018-10-08       Impact factor: 3.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.